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background:  The role of revascularization with percutaneous coronary intervention (PCI) in the management of Unstable Angina and Non-ST-
Elevation Myocardial Infarction (UA/NSTEMI) remains controversial. Previous post-hoc analysis of randomized clinical trials has shown that troponin 
elevation permits the determination of high-risk patients who may benefit more from PCI. We further explored this hypothesis in clinical practice, 
attempting to address previous concerns on baseline risk of patients as assessed by biomarker status (UA vs.NSTEMI).
methods: The study population of the present analysis consists of the International Survey of Acute Coronary Syndromes in Transitional Countries 
(ISACS-TC/NCT01218776) registry participants. This is an observational study of 1940 UA/NSTEMI patients; of these 805 underwent routine PCI and 
1135 received medical therapy (MT) alone. The primary outcome was all-cause in-hospital mortality.
results: Patients treated with MT alone included a greater number of females (37% vs. 26.2%, p<0.001), had higher rates of cerebrovascular 
disease (7.2% vs. 3.1%, p=0.0001), diabetes (30.6% vs. 21.5%, p<0.001) and Killip class ≥ 2 (21.1% vs. 17.1%, p=0.1759), but lower rates 
of smoking (24.6% vs. 40.3%, p<0.001) and hypercholesterolemia (42.8% vs. 46.4%, p=0.1466) than their counterpart undergoing PCI. In 
multivariable regression analysis, in-hospital revascularization was independently associated with a reduction of the primary outcome when 
compared with MT: adjusted odd ratio (OR) 0.37 (95% confidence interval [CI]: 0.19-0.72, p=0.003) and 3.24 (95%CI 1.44 - 7.30, p=0.004). 
Analysis restricted to patients with NSTEMI showed attenuation in the effect size for all-cause mortality: adjusted OR:0.49; 95% CI: 0.25-0.96, 
p=0.037 and 2.32 (95% CI: 1.02 - 5.29, p=0.045).
Conclusion: Contrary to expectations, a routine strategy with PCI was associated with greater benefits in patients with negative troponin status 
(UA). Potential clinical benefits from PCI do not seem to favorably affect the overall prognosis of the index myocardial infarction (NSTEMI). Larger 
randomized studies are required to prove this conclusively.
